Dr. Raymond David Pastore, MD

Dr. Pastore practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Pastore's NPI, 1124027487, was assigned on July 19, 2005. Dr. Pastore graduated from New York University School of Medicine in 1995. Dr. Pastore holds New York license 205053.

Dr. Pastore's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Pastore's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Pastore to 2 more clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pastore practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Pastore's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Pastore is board certified in hematology by the American Board of Internal Medicine. Dr. Pastore is licensed in New York.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Pastore treats.

CMS data shows 53,619 Medicare services from Dr. Pastore across 17 procedure codes in 2024, for 694 Medicare patients. Medicare paid $274,902 for them.

CMS counts 694 Medicare patients who saw Dr. Pastore in 2024. The largest group is 75 to 84, with 308 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pastore's median patient age at 73, with 59% women.

In 2024, Dr. Pastore wrote 265 Medicare Part D claims for 96 patients. 59% of them were for generic drugs. CMS names the drug for 153 of them, across 4 drugs with 11 or more claims each, at $80,600 in total drug cost. In 2023, CMS named 146 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Pastore for performance year 2024, reported through an alternative payment model (APM). Dr. Pastore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pastore as offering telehealth.

Dmand AI links 10 papers to Dr. Pastore, published from 2015 to 2020. 2020 was the busiest year, with 2. The most frequent topics are Amyloidosis, Black or African American and Black People. Dr. Pastore's most frequent co-authors are Peter Martin, MD, Ethel Cesarman, MD and Jim Way Cheung, MD.

CMS Open Payments shows 346 general payments to Dr. Pastore from 45 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. Bristol-Myers Squibb Company paid the most, $17,884.

Dmand AI lists 2 awards for Dr. Pastore, most recently CMS Stage 1 EHR in 2014.

Dr. Pastore graduated from New York University School of Medicine in 1995. Dr. Pastore is a member of ACP.

Dr. Pastore is in network with 15 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.